» Articles » PMID: 38921036

Obesity As a Confounding Factor in the Diagnosis of Wilson's Disease: Case Report of Two Siblings with the Same Genotype but Different Clinical Courses

Overview
Publisher MDPI
Specialty Molecular Biology
Date 2024 Jun 26
PMID 38921036
Authors
Affiliations
Soon will be listed here.
Abstract

Wilson's disease (WD) is a biallelic disease-causing variant in the gene on chromosome 13q14.3 that results in copper accumulation in many organs, particularly the liver and brain. The phenotypic spectrum is wide and symptoms at onset can be heterogeneous. We describe two Sicilian siblings, a young man and his elder sister, both compound heterozygous for the variants c.1286-2A>G and c.2668G>A (p.Val890Met) in the gene. The male patient presented with liver cirrhosis, which quickly progressed to end-stage liver disease (Child-Pugh score = C10), while his sister had moderate steatotic liver disease (SLD). Our findings highlight that SLD may not always be related to obesity in overweight patients, especially when there are other potential risk factors such as a family history of chronic liver disease, or the persistence of high transaminase despite the adoption of adequate dietary and pharmacological intervention. Screening for conditions such as WD could identify patients at risk of developing SLD and avoid delays in diagnosis. Phenotypic variability in WD is considerable; therefore, further studies are needed to identify which WD patients have a greater risk of developing SLD and determine factors that can predict the severity of the disease.

References
1.
Sapuppo A, Pavone P, Pratico A, Ruggieri M, Bertino G, Fiumara A . Genotype-phenotype variable correlation in Wilson disease: clinical history of two sisters with the similar genotype. BMC Med Genet. 2020; 21(1):128. PMC: 7291468. DOI: 10.1186/s12881-020-01062-6. View

2.
Gu Y, Kodama H, Du S, Gu Q, Sun H, Ushijima H . Mutation spectrum and polymorphisms in ATP7B identified on direct sequencing of all exons in Chinese Han and Hui ethnic patients with Wilson's disease. Clin Genet. 2004; 64(6):479-84. DOI: 10.1046/j.1399-0004.2003.00179.x. View

3.
Rodriguez-Castro K, Hevia-Urrutia F, Sturniolo G . Wilson's disease: A review of what we have learned. World J Hepatol. 2015; 7(29):2859-70. PMC: 4678372. DOI: 10.4254/wjh.v7.i29.2859. View

4.
Schilsky M, Roberts E, Bronstein J, Dhawan A, Hamilton J, Rivard A . A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology. 2022; 77(4):1428-1455. DOI: 10.1002/hep.32805. View

5.
Shribman S, Marjot T, Sharif A, Vimalesvaran S, Ala A, Alexander G . Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the Liver. Lancet Gastroenterol Hepatol. 2022; 7(6):560-575. DOI: 10.1016/S2468-1253(22)00004-8. View